A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)

Clinical trial NCT04751955 · WITHDRAWN

Trial details

NCT number: NCT04751955
Sponsor: Korean Cancer Study Group
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic

Start date: 2022-01-01
Primary completion: 2023-10-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.